Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GEBBIA, Nicolo'
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.486
EU - Europa 4.625
AS - Asia 1.685
SA - Sud America 357
AF - Africa 58
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 16.228
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.447
IT - Italia 1.052
FI - Finlandia 898
UA - Ucraina 816
CN - Cina 734
SG - Singapore 652
DE - Germania 646
BR - Brasile 319
IE - Irlanda 262
SE - Svezia 228
GB - Regno Unito 227
RU - Federazione Russa 152
FR - Francia 91
RO - Romania 62
IN - India 60
KR - Corea 57
BE - Belgio 48
CI - Costa d'Avorio 32
NL - Olanda 28
TR - Turchia 28
IR - Iran 26
PL - Polonia 21
ES - Italia 18
CA - Canada 17
AT - Austria 16
GR - Grecia 16
MY - Malesia 15
MX - Messico 14
CH - Svizzera 12
HK - Hong Kong 12
IQ - Iraq 12
UZ - Uzbekistan 11
VE - Venezuela 10
AR - Argentina 9
MA - Marocco 9
PH - Filippine 9
EG - Egitto 8
EU - Europa 8
JP - Giappone 8
CZ - Repubblica Ceca 7
VN - Vietnam 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
LB - Libano 5
PE - Perù 5
PK - Pakistan 5
TW - Taiwan 5
BG - Bulgaria 4
EC - Ecuador 4
ID - Indonesia 4
NZ - Nuova Zelanda 4
AL - Albania 3
AZ - Azerbaigian 3
BD - Bangladesh 3
BO - Bolivia 3
IL - Israele 3
NP - Nepal 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
BY - Bielorussia 2
CL - Cile 2
CO - Colombia 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
LU - Lussemburgo 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
Totale 16.228
Salva come PNG Salva come JPEG
Città #
Fairfield 1.243
Chandler 847
Ashburn 802
Woodbridge 720
Wilmington 611
Houston 553
Ann Arbor 539
Seattle 492
Jacksonville 422
Singapore 418
Cambridge 386
Dublin 256
Des Moines 230
Palermo 225
Medford 219
Nanjing 151
Princeton 145
Altamura 144
Lawrence 105
Tulsa 102
New York 97
Boardman 95
San Diego 81
Santa Clara 77
Dearborn 74
The Dalles 68
Beijing 64
Milan 57
Ludwigshafen am Rhein 52
Shenyang 49
Brussels 48
Nanchang 46
Jinan 45
Seongnam 45
Hebei 44
Helsinki 44
Changsha 41
San Mateo 39
Tianjin 37
Abidjan 32
Saint Petersburg 31
Jiaxing 30
London 30
Munich 30
Council Bluffs 29
Kumar 26
Los Angeles 25
Guangzhou 24
Kitzingen 24
São Paulo 24
Venice 21
Falls Church 20
Zhengzhou 20
Bremen 19
Columbus 18
Rome 18
Tehran 18
Ningbo 17
San Paolo di Civitate 17
Verona 17
Chicago 16
Nuremberg 16
Auburn Hills 15
Berlin 13
Izmir 13
Lanzhou 13
Phoenix 13
Washington 13
Kilburn 12
Kraków 12
Düsseldorf 11
Hangzhou 11
Brasília 10
Kunming 10
Moscow 10
Redwood City 10
Athens 9
Belo Horizonte 9
Haikou 9
Pune 9
Rio de Janeiro 9
Taiyuan 9
Fuzhou 8
Norwalk 8
Dallas 7
Edinburgh 7
Mazara del Vallo 7
Monza 7
Taizhou 7
Toronto 7
Central District 6
Erice 6
Florence 6
Frankfurt am Main 6
Guarulhos 6
Indiana 6
Porto Alegre 6
Salvador 6
Shanghai 6
Durham 5
Totale 10.572
Salva come PNG Salva come JPEG
Nome #
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 292
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment 285
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. 234
Heterocyclic and Phenyl Double-Bond-Locked Combretastatin Analogues Possessing Potent Apoptosis-inducing activity in HL60 and in MDR Cell lines 222
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 206
Stilbene-based anticancer agents: Resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism. 206
The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse 204
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 196
Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells 196
Anti-endothelin drugs in solid tumors 194
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy 193
EGFR genomic alterations in cancer: prognostic and predictive values 185
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients 185
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer 182
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 179
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. 179
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 179
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 178
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. 175
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 174
Overexpression of cyclin D1 and interaction between p27(Kip1) and tumour thickness predict lymph node metastases occurrence in lower lip squamous cell carcinoma 173
Studies on the apoptotic activity of natural and synthetic retinoids: discovery of a new class of synthetic terphenyls that potently support cell growth and inhibit apoptosis in neuronal and HL-60 cells 171
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers 166
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. 163
Clinical presentation and treatment of gastrointestinal stromal tumors. 162
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. 162
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells. 162
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 162
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 162
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 160
Emotional expression and coping style in female breast cancer. 160
Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications 158
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer. 157
Ductal lavage: a way of carefully tracing the breast-secreting duct 157
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy 153
BRAFV600E Mutation and p27kip1 Expression in Papillary Carcinomas of the Thyroid ≤1 cm and Their Paired Lymph Node Metastases 153
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale 151
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells 151
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 147
miR-20b Modulates VEGF Expression by Targeting HIF-1a and STAT3 in MCF-7 Breast Cancer Cells 147
Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia 144
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 138
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma 138
ELF regimen in advanced gastrointestinal malignancies: An analysis of its clinical effectiveness and toxicity 138
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome 137
A case of squamocellular uterine cervix carcinoma metastatic to the skin with enterocutaneous fistula. 135
Antiproliferative Agents That Interfere with the Cell Cycle at the G(1)-->S Transition: Further Development and Characterization of a Small Library of Stilbene-Derived Compounds 133
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients. 132
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. 129
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 128
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer 127
Carcinoma squamocellulare del pene localmente avanzato: associazione tra risposta clinica e modificazione dei livelli di ferritina sierica. 127
Triplet schedule of weekly 5-Fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: A dose-finding and phase II study 125
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases 123
A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma 121
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. 119
Bortezomib: a new pro-apoptotic agent in cancer treatment. 117
Alexithymia and coping style in women going to visit in a breast cancer center. 115
Effetti antileucemici di due stilbeni identificati in uve provenienti da vigneti affetti da peronospora e Botrytis cinerea 115
Ductal Lavage: a valid method of risk assessment and of early diagnosis in breast cance 115
Effects of Propolis in cancer cells 113
Deep vein thrombosis and pulmonary embolism can be treated at home in cancer patients 111
Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer. 111
Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: Clinical implications 109
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106). 108
Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience. 108
Haemopoietic effects of 7 alpha, 17 beta Dimethyltestosterone 108
PML down-regulation in soft tissue sarcomas 107
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. 106
“Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey” 106
A phase II study of Oxaliplatin Capecitabine chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 105
Persistance of residual vein thrombosis after an episode of deep vein thrombosis of the lower limbs and the risk of new cancer and cardiovascular disease. 105
A phase II study of capecitabine oxaliplatin chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 105
Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas 105
Ondasetron versus granisetron in the prevention of chemotherapy‐induced nausea and vomiting. Results of a prospective randomized trial 102
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth International Congress on Anticancer Treatment February 9th 12th 2004, Paris accepted for oral presentation 100
Emergenze metaboliche 99
Managing cancer patients with acute venous thromboembolism: exploring safe alternatives to hospitalisation 97
ACTIVIN A CIRCULATING LEVELS IN PATIENTS WITH PRIMARY OSTEOPOROSIS OR BONE METASTASES FROM BREAST CANCER 96
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. 96
New potential circulating markers for the therapeutic monitoring of metastatic bone disease. 95
Studio di phase II: Docetaxel settimanale come seconda linea chemioterapia nel carcinoma prostatico avanzato. 95
Cathepsin D, B and L circulating levels as prognostic markers of malignant progression 95
Studio del pattern di distribuzione dell'Activina A nel siero di pazienti con metastasi ossee da carcinoma prostatico in trattamento con acido zoledronico 94
Alexithymia and copyng style in women going to visit in a breast cancer center 93
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases. 92
PML down-regulation in soft tissue sarcomas. 92
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study 91
“Effects of combretastatin analogues on leukemic cell lines and normal hemopoietic cells” 86
Antitumor effects of the grape stilbenes resveratrol and piceatannol on multidrug and apoptosis resistant HL60 leukemia cells" 85
Cardiotossicità e Cardioprotezione. 85
Ras family genes: An interesting link between cell cycle and cancer 85
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 84
Activin A circulating levels in patients with osteoporosis or bone metastasis from breast cancer 84
Clinical guidelines for the management of gastrointestinal stromal tumors 83
“Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer:the IGCS-COL multicentre, randomised, phase III study” 83
Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis. 83
Epirubicina (EPI ) e Docetaxel (DOC ) come chemioterapia primaria ( C P ) nel trattamento del carcinoma mammario localmente avanzato ( CMLA ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 82
Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocytes-mediated activation mechanism. 82
GIST, Tumori stromali gastrointestinali (Gist: linee guida diagnostico-terapeutiche) 81
Totale 13.624
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.714
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020616 0 0 0 0 0 0 0 0 0 192 281 143
2020/20212.328 79 175 90 483 322 81 176 114 233 164 175 236
2021/20221.817 77 437 21 91 93 52 103 86 237 223 91 306
2022/20232.341 258 446 43 250 240 370 177 171 256 15 85 30
2023/20241.061 34 149 86 91 68 214 114 110 5 31 15 144
2024/20251.752 52 169 181 285 105 84 197 198 192 289 0 0
Totale 16.686